Vertex Pharmaceuticals
A page on organisations in our medical research coverage, part of our health reporting, alongside the 5 reports filed on it so far.
ADARx files for IPO to fund three
ADARx Pharmaceuticals has filed for an initial public offering to raise funds for advancing its pipeline of siRNA therapies, including mid- and...
Novartis, Ionis heart drug fails in major Phase 3 trial
Novartis and Ionis Pharmaceuticals' experimental drug pelacarsen failed to reduce heart attacks, strokes or death in a Phase 3 study of over 8,000...
Ionis' Zanvastro Wins First FDA Approval for Alexander
The FDA has approved Ionis Pharmaceuticals' Zanvastro, the first treatment for the rare neurological disorder Alexander disease.
Teva bids $57.5M for bankrupt BioXcel assets
Teva Pharmaceuticals has been named the stalking horse bidder to acquire BioXcel Therapeutics' neuroscience portfolio for $57.5 million upfront...
Regeneron's Pasatru Receives FDA Approval for Rare Bone Disease
Regeneron Pharmaceuticals' Pasatru has earned FDA approval for treating fibrodysplasia ossificans progressiva, a rare condition causing abnormal bone...